Knockdown of PRDX1 attenuated the up-regulation of GADD45G and γ-H2AX with Celastrol or compound 19-048 treatment, which is consistent with the efficacy assessment for tumor volume and weight (Fig. 7d). The gene discussed is GADD45G; the disease is neoplasm.